Home
Perceptive Advisors reported a 9.99% stake in enGene Therapeutics ENGN · 6,770,605 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 9.99%
- Last report
- First report
- Shares held
- 6,770,605 sh
- Class
- Common Shares
- Holder
- Perceptive Advisors
- Event date
- 25/11/11
- Filed
- 25/11/18
First 5%+ report · 9.99% stake
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 25/10/12~25/12/11Perceptive Advisors's other 5% stake reports
- Perceptive Advisors
5% stakeNurix Therapeutics
5% stakeNurix Therapeutics
NRIX
5.3% stake
5,536,629 sh
5.3% stake
Filed 09/23
- Perceptive Advisors
5% stakeImmatics
5% stakeImmatics
IMTX
7.6% stake
11,418,016 sh
7.6% stake
Filed 08/27
- Perceptive Advisors
5% stakeLeonaBio
5% stakeLeonaBio
LONA
19.99% stake
1,889,403 sh
19.99% stake
Filed 08/25
- Perceptive Advisors
5% stakeSolid Biosciences
5% stakeSolid Biosciences
SLDB
11.2% stake
12,046,579 sh
11.2% stake
Filed 08/14
- Perceptive Advisors
5% stakeSpyre Therapeutics
5% stakeSpyre Therapeutics
SYRE
4.9% stake
4,319,496 sh
4.9% stake
Filed 08/14
